Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15809708rdf:typepubmed:Citationlld:pubmed
pubmed-article:15809708lifeskim:mentionsumls-concept:C0242957lld:lifeskim
pubmed-article:15809708lifeskim:mentionsumls-concept:C0555198lld:lifeskim
pubmed-article:15809708lifeskim:mentionsumls-concept:C0012920lld:lifeskim
pubmed-article:15809708lifeskim:mentionsumls-concept:C1704824lld:lifeskim
pubmed-article:15809708lifeskim:mentionsumls-concept:C0178655lld:lifeskim
pubmed-article:15809708lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:15809708pubmed:issue5lld:pubmed
pubmed-article:15809708pubmed:dateCreated2005-4-5lld:pubmed
pubmed-article:15809708pubmed:abstractTextPediatric malignant non-brainstem glioma (PMNBG) is a rare tumor that accounts for only about five percent of childhood intracranial neoplasms. DNA topoisomerase IIalpha (TIIalpha) is a novel marker of cell-cycle turnover and a target of high-risk chemotherapy in PMNBG. We have shown that TIIalpha protein expression strongly correlates with event-free and overall survival in these malignancies. The molecular mechanism causing the varying TIIalpha protein expression in PMNBG remains unknown. Utilizing a combined approach of immunocytochemistry-based morphology guidance, laser-assisted microdissection and quantitative real-time PCR, we report a low-level co-amplification of the neighboring TIIalpha and Her-2/neu gene loci on chromosome 17q11-q22 in one of seventeen examined PMNBGs. Analysis of both genes by real-time PCR in the crude tumor samples without prior tissue heterogeneity reduction via laser microdissection, resulted in loss of detection of amplification of the syngeneic Her-2/neu locus. Gene dosage assessment in a microscopically distant tumor area revealed no amplification of either gene. Our results suggest that low-level amplification of the TIIalpha gene locus may be a sporadic mechanism of increased TIIalpha protein expression in PMNBG, which can coincide with low-level amplification of Her-2/neu. The observed intratumor genetic heterogeneity for TIIalpha in PMNBGs may have an impact on the relevance of TIIalpha as a biological constituent of outcome in these neoplasms.lld:pubmed
pubmed-article:15809708pubmed:languageenglld:pubmed
pubmed-article:15809708pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15809708pubmed:citationSubsetIMlld:pubmed
pubmed-article:15809708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15809708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15809708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15809708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15809708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15809708pubmed:statusMEDLINElld:pubmed
pubmed-article:15809708pubmed:monthMaylld:pubmed
pubmed-article:15809708pubmed:issn1019-6439lld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:HamiltonRonal...lld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:PollackIan...lld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:WernerMartinMlld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:BredelMarkusMlld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:VolkBenediktBlld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:LassmannSilke...lld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:KnothRolfRlld:pubmed
pubmed-article:15809708pubmed:authorpubmed-author:BredelClaudia...lld:pubmed
pubmed-article:15809708pubmed:issnTypePrintlld:pubmed
pubmed-article:15809708pubmed:volume26lld:pubmed
pubmed-article:15809708pubmed:ownerNLMlld:pubmed
pubmed-article:15809708pubmed:authorsCompleteYlld:pubmed
pubmed-article:15809708pubmed:pagination1187-92lld:pubmed
pubmed-article:15809708pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:meshHeadingpubmed-meshheading:15809708...lld:pubmed
pubmed-article:15809708pubmed:year2005lld:pubmed
pubmed-article:15809708pubmed:articleTitleDNA topoisomerase IIalpha and Her-2/neu gene dosages in pediatric malignant gliomas.lld:pubmed
pubmed-article:15809708pubmed:affiliationDepartment of General Neurosurgery, Neurocenter, University of Freiburg, D-79106 Freiburg, Germany. mbredel@stanford.edulld:pubmed
pubmed-article:15809708pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:2064entrezgene:pubmedpubmed-article:15809708lld:entrezgene
entrez-gene:7153entrezgene:pubmedpubmed-article:15809708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15809708lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15809708lld:entrezgene
lhgdn:association:46718lhgdn:found_inpubmed-article:15809708lld:lhgdn
lhgdn:association:54462lhgdn:found_inpubmed-article:15809708lld:lhgdn